TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection
Press Releases

TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection

SUZHOU, China, Nov 18, 2024 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage company dedicated to developing novel therapies to address unmet needs in infectious diseases, announced today the successful completion of

logo salamanca press

Salamanca Press

Local & Social